• Elderly Patients With Early-stage Lung Cancer Good Candidates For SBRT, Study Suggests
  • Pharmatest Develops ‘Humanized’ Mouse Model of Bone Metastasis to Study New Therapies
  • FDA Grants Orphan Drug Status to TPX-0005 for Non-small Cell Lung Cancers with Gene Mutations
  • Mutation Burden and PD-L1 Levels Can Help Predict Patient’s Response to Opdivo, Study Finds
  • Patient Enrollment Paused in Phase 3 Trial of Tedopi in NSCLC
  • Memory T-cells Within Lung Tumors Predict Good Patient Outcome, Study Shows
  • FDA Approves Tafinlar, Mekinist Combo to Treat BRAF V600E Non-Small Cell Lung Cancer
  • Entinostat-Keytruda Clinical Trial in NSCLC Will Proceed to Next Stage
  • ASTRO Issues Guidelines for Using High-dose Focused Radiation in Early-stage Lung Cancer
  • 70% of Patients with Brain Cancer Originating in the Lungs Responded to Tagrisso, Trial Shows
  • Keytruda Increases Survival of Lung Cancer Patients, Compared with Standard Chemo, Update Shows
  • Alecensa Doubles Time to Disease Progression in Untreated ALK+ NSCLC Patients Compared to Xalkori